"The
Use of Cranial Electrotherapy
Stimulation to Block Fear
Perception in Phobic Patients."
By Ray B. Smith, Ph.D.
and Frank N. Shiromoto, M.F.C.C.
in Current Therapeutic
Research, Vol. 51, No.
2, February 1992.
"Thirty-one
persons responded to public
media announcements requesting
subjects for a phobia treatment
project. They were asked to
imagine themselves in their
worst phobic situation, then
rate their fear on a scale
from no fear to extreme fear.
They were then given 30 minutes
of (Alpha-Stim) CES, after
which they were asked to frighten
themselves again and to rate
the fear as before. The patients
were successful in generating
a fear response, which, in
turn, appeared to be mitigated
by CES."
"Overall,
while 77% of the subjects
rated their fear as moderate
to extreme going into the
study, 85% rated their fear
from very low to none following
30 minutes of CES...From our
data, it would appear that
CES may be successfully instituted
while patients are on some
form of supportive medications
and might be a useful tool
with which to withdraw patients
from such medications, should
the physician desire."
"I am writing
this letter in support of
the use of the Alpha-Stim
for chronic pain management.
Our Pain Management Clinic
manages over 100 patients
and we have approximately
25 patients who are currently
utilizing the Alpha-Stim on
a regular basis. These patients
all experience either complete
or significant pain relief
from their Alpha-Stim treatments.
Many of these patients failed
all other therapies including
medication, physical therapy,
myofascial injections, nerve
blocks, and biofeedback or
other relaxation techniques.
The ability of these patients
to treat themselves at home
also saves time and money
spent on clinic visits. Their
significant pain relief often
increases their productivity.
They miss less work and are
able to function better when
they are at work. The effectiveness
of the therapy and the convenience
of home treatment make the
Alpha-Stim an invaluable tool
in the management of chronic
pain."
P.J.
Lashley-Alder, M.D., Major,
USAF Chief of Anesthesia,
WBAFB, Ohio
"Electrotherapy
and Hyperbaric Oxygen: Promising
Treatments for Postradiation
Complications."
By Gordon E. King, D.D.S.,
Jan Scheetz, B.S., Rhonda
F. Jacobs, D.D.S., M.S., and
Jack W. Martin, D.D.S., M.S.
in the Journal of Prosthetic
Dentistry, Vol. 62, No.
3, September 1989. Also published
in the book, Emerging Electromagnetic
Medicine edited by M.E.
O'Conner, R.H.C. Bentall and
J.C. Monahan, Springer-Verlag,
New York, 1990.
This study
addressed 37 head and neck
cancer patients with postsurgery
and radiation sequelae over
a three year period at The
University of Texas M.D. Anderson
Cancer Center, Houston, Texas.
The conditions and treatments
of the patients varied so
"a valid comparison of their
treatment modalities was not
possible."
In the Discussion,
the following statement was
made of a patient who only
received Alpha-Stim treatment:
"At the end of the two week
period, a marked change had
occurred in the texture and
color of the irradiated tissues...there
was a marked increase in blood
flow and cellular metabolism
within this area...[this]
was allowing tissues to repair
and revascularize in an area
that would otherwise experience
progressive ischemia and fibrosis."
The authors
concluded that, "The clinical
impression at M.D. Anderson
Cancer Center is that electrotherapy
and hyperbaric oxygen is achieving
a degree of tissue repair
and revascularization of the
irradiated field...It is apparent
that these modalities have
relieved discomfort, enhanced
healing of irradiated hard
and soft tissues, and improved
the quality of the irradiated
soft tissues."
"Low
Intensity Transcranial Electrostimulation
Improves the Efficacy of Thermal
Biofeedback and Quieting Reflex
Training in the Treatment
of Classical Migraine Headaches."
By Philip Brotman, Ph.D.,
in Medical Electronics,
No. 118, September 1989.
This is
a double-blind study of 36
female subjects diagnosed
as having classical migraine
headaches. The frequency and
intensity of the migraine
were tracked over eight treatment
sessions and three follow-up
sessions under the direction
of Charles S. Stroebel, Ph.D.,
M.D. at the Stress Medicine
Clinic of Hartford, Connecticut.
"Statistical
comparisons (t-tests) showed
that the group treated with
combined (Alpha-Stim) CES,
TB and QR resulted in faster
decreases in headache symptoms,
particularly during a 3-month
follow-up period...Those groups
which did not receive the
CES treatment were subsequently
treated with CES. They, in
turn, achieved headache reductions
comparable to those obtained
by the combined TB, QR, CES
group in this study."
"Cranial
electrotherapy stimulation
may contribute to both the
rapid rise in finger temperature
during each session and homeostatic
rise in finger temperature
through its effect on the
hypothalamus."
"Biofeedback
and Electromedicine Reduce
the Cycle of Pain-Spasm-Pain
in Low Back Patients."
By Stephen I. Zimmerman, Ph.D.,
R.P.T., and Fred N. Lerner,
Ph.D. in Medical Electronics,
No. 117, June 1989.
Forty-two
subjects with low back pain
completed this 20 treatment
study by receiving (Alpha-Stim)
electrical stimulation and
EMG biofeedback (Group I),
biofeedback (Group II) or
electrical stimulation (Group
III). Measures used to assess
treatment outcome included
Subjective Units of Disturbance
(SUDS), trunk mobility evaluation,
daily pain record cards, microvoltage
readings and pre- and post-treatment
MMPI.
"At the conclusion
of the study it was evident
that a greater reduction in
perceived pain was noted by
the Biofeedback/Electrical
Stimulation and Electrical
Stimulation groups than that
exhibited by the Biofeedback
group."
"One of the
most striking findings of
the study was the decrease
across all treatment conditions
in the degree of psychological
distress experienced by the
participants. Clinically significant
decrements in impairment were
found to exist on 13 of 17
MMPI subscales which were
examined (Lie, Faking Bad,
Sophisticated Liar, Hypochondriasis,
Depression, Hysteria, Psychopathic
Deviate, Paranoid, Psychasthenia,
Schizophrenia, Caudality,
Low-Back Pain, and Somatic
Complaints). The findings
denote a shift from individuals
who present themselves, in
the aggregate, as displaying
clinically significant effects
which connote persons who
are overly sensitive towards
others, with an increased
emphasis upon their own symptomatology
and decreased expectancy that
others will be supportive
and empathetic, while at the
same time use physical complaints
to focus attention upon themselves
so as to manipulate others,
towards more open and accepting
individuals who experience
less stressful and more adaptive
patterns of functioning."
"The
Effects of Cranial Electrotherapy
Stimulation and Multisensory
Cognitive Therapy on the Personality
and Anxiety Levels of Substance
Abuse Patients."
By Stephen J. Overcash, Ph.D.
and Alan Siebenthall, Ed.D.,
in Medical Electronics,
No. 116, April 1989.
Thirty-two
patients who smoke marijuana
were divided into two groups.
Psychological testing using
the 16PF Personality Test
was given initially and at
the end of the ten sessions.
Psychophysiological stress
profiles were given during
each session. The control
group (CG) was treated with
EMG biofeedback, Quieting
Response relaxation tapes
and psychotherapy. The experimental
group (ExG) had the same treatment
with the addition of (Alpha-Stim)
CES and multisensory cognitive
therapy (Relax and Learn Software
which superimposes positive
affirmations over a relaxing
videotape). All patients were
also given weekly blood tests
to determine their use of
marijuana.
"Although
the nervous tension level
was reduced significantly
in both groups, the results
of the study show significant
differences between the two
groups in five different areas.
An ANOVA performed on the
results of the patients EMG
indicated that the ExG was
more significantly able to
reduce their frontalis EMG
than the control group. In
addition, the ExG was able
to reach the same level of
relaxation after 8 sessions
that it took the CG to reach
in 10 sessions. There were
four significant differences
in the subtests of the 16PF
Personality Test. In the self
sufficiency subtest, the ExG
was significantly more planful
than the CG. While the ExG
became significantly more
assertive in the dominance
subtest area, there was no
significant difference in
the CG. Another subtest showing
a significant difference between
the groups was ego strength.
The ExG appeared to become
more decisive in handling
their interactions with others,
whereas, there was no significant
difference in the CG." The
researchers concluded, "This
may have occurred because
the (Alpha-Stim) CES may have
allowed the patients to become
more relaxed and more open
to the affirmations used with
the multisensory emotional
therapy."
"Neuroelectric
Therapy Eliminates Xerostomia
During Radiotherapy - A Case
History."
By Nathalie S. Boswell, M.A.,
in Medical Electronics,
No. 115, February, 1989.
"A patient
receiving radiation therapy
for squamous cell carcinoma
of the right tonsilar area
was given (Alpha-Stim) Neuroelectric
Therapy immediately following
each radiation treatment.
The following adverse reactions
to radiation were expected:
irreversible xerostomia, temporary
dysgeusia, throat pain and
possible mucositis and radiation
dermatitis. Due to the NET
treatments, all adverse reactions
were either eliminated or
reduced drastically. Xerostomia
and dysgeusia were eliminated.
The patient required no regimen
of pain medication because
NET reduced the level of pain
each day after radiation;
he showed no signs of mucositis
or radiation dermatitis at
any time...this is highly
unusual since some degree
of xerostomia and mucositis
is anticipated in all irradiated
patients."
"Several
patients have been seen at
the VA Medical Center for
NET treatment for post-radiation
dryness, with equally good results."